Skip to main content
search

Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19.

Purpose: To study the biology and identify markers of severe cytokine release
syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome
(ICANS) in children after chimeric antigen receptor T-cell (CAR T)
treatment.

Close Menu